Literature DB >> 9420783

Assessment of acute thrombolysis with newly developed myocardial single-photon emission computed tomographic techniques.

T Nishimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 9420783     DOI： 10.1016/s1071-3581(95)80029-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  28 in total

Review 1.  Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.

Authors:  R M Califf; L Harrelson-Woodlief; E J Topol
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

2.  Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate.

Authors:  B A Khaw; H W Strauss; R Moore; J T Fallon; T Yasuda; H K Gold; E Haber
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

3.  Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery.

Authors:  G M Santoro; G Bisi; R Sciagrà; M Leoncini; P F Fazzini; U Meldolesi
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

4.  Serial assessment of denervated but viable myocardium following acute myocardial infarction in dogs using iodine-123 metaiodobenzylguanidine and thallium-201 chloride myocardial single photon emission tomography.

Authors:  T Nishimura; H Oka; M Sago; T Matsuo; T Uehara; H Noda; H Takano
Journal:  Eur J Nucl Med       Date:  1992

5.  Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk.

Authors:  L L Johnson; D W Seldin; A M Keller; R M Wall; K Bhatia; C O Bingham; M E Tresgallo
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

6.  Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate.

Authors:  G A Beller; B A Khaw; E Haber; T W Smith
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

7.  Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application.

Authors:  J D Minardo; M M Tuli; B H Mock; R E Weiner; H P Pride; H N Wellman; D P Zipes
Journal:  Circulation       Date:  1988-10       Impact factor: 29.690

8.  Fatty acid myocardial imaging using 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model).

Authors:  T Nishimura; M Sago; K Kihara; H Oka; T Shimonagata; T Katabuchi; M Hayashi; T Uehara; K Hayashida; H Noda
Journal:  Eur J Nucl Med       Date:  1989

9.  Fluoromisonidazole. A metabolic marker of myocyte hypoxia.

Authors:  G V Martin; M D Cerqueira; J H Caldwell; J S Rasey; L Embree; K A Krohn
Journal:  Circ Res       Date:  1990-07       Impact factor: 17.367

10.  Effect of infarct location on myocardial salvage assessed by technetium-99m isonitrile.

Authors:  T F Christian; R J Gibbons; B J Gersh
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.